Literature DB >> 17457095

Trends in HIV prevalence in blood donations in Europe, 1990-2004.

Giedrius Likatavicius1, Françoise F Hamers, Angela M Downs, Jane Alix, Anthony Nardone.   

Abstract

INTRODUCTION: The comparison of HIV prevalence among blood donations in European countries provides an indication of the relative safety of the blood supply in different countries and over time.
METHODS: Data between 1990 and 2004 on annual numbers of blood donations and HIV prevalence in blood donations were collected from national correspondents in the 52 countries of the World Health Organization European Region. Data are presented for three geographic areas: West, Centre and East.
RESULTS: Since 1990, the number of blood donations has declined by 43% in the East and by 26% in the Centre, while remaining relatively stable in the West. In 2004, the number of blood donations was more than twice as high in the West in comparison with the East and the Centre. Over the same period, HIV prevalence among blood donations increased dramatically in the East, remained stable in the Centre and declined in the West. Since 2001, HIV prevalence levels of more than 10 per 100 000 donations were reported from six countries in the East (with a high of 128/100 000 in Ukraine), whereas in the rest of Europe the reported national HIV prevalence levels were lower than 10/100 000 donations. The prevalence of HIV was much lower among donations from repeat donors than from first-time donors.
CONCLUSION: In some eastern European countries public health interventions, such as deferring individuals at risk of HIV infection from donating blood and constituting a pool of regular donors, are urgently needed to assure the safety of the blood supply.

Entities:  

Mesh:

Year:  2007        PMID: 17457095     DOI: 10.1097/QAD.0b013e3280b07dd7

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil.

Authors:  Ester C Sabino; Thelma T Gonçalez; Anna Bárbara Carneiro-Proietti; Moussa Sarr; João Eduardo Ferreira; Divaldo A Sampaio; Nanci A Salles; David J Wright; Brian Custer; Michael Busch
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

2.  Blood donor deferral policies across Europe and characteristics of men whohave sex with men screened for human immunodeficiency virus in bloodestablishments: data from the European Men-who-have-sex-with-men Internet Survey (EMIS).

Authors:  Susanne B Schink; Ruth Offergeld; Axel J Schmidt; Ulrich Marcus
Journal:  Blood Transfus       Date:  2017-03-23       Impact factor: 3.443

3.  The impact of simple donor education on donor behavioral deferral and infectious disease rates in São Paulo, Brazil.

Authors:  Thelma T Gonçalez; Ester C Sabino; Nanci Alves Salles; Cesar de Almeida-Neto; Alfredo Mendrone; Pedro E Dorlhiac-Laccer; Jing Liu; Edward L Murphy; George B Schreiber
Journal:  Transfusion       Date:  2009-12-09       Impact factor: 3.157

4.  Knowledge, attitudes and motivations among blood donors in São Paulo, Brazil.

Authors:  Thelma T Goncalez; Ester C Sabino; Sanny Chen; Nanci Alves Salles; Dalton A F Chamone; Willi McFarland; Edward L Murphy
Journal:  AIDS Behav       Date:  2008-04-04

5.  Association of ABO and Rh Blood Groups to Blood-Borne Infections among Blood Donors in Tehran-Iran.

Authors:  Fatemeh Mohammadali; Aliakbar Pourfathollah
Journal:  Iran J Public Health       Date:  2014-07       Impact factor: 1.429

6.  Confidential donation confirmation as a alternative exclusion.

Authors:  Thelma T Gonçalez
Journal:  Rev Bras Hematol Hemoter       Date:  2011

7.  The Prevalence and Trends of Hepatitis B, Hepatitis C, and HIV among Voluntary Blood Donors in Kohgiluyeh and Boyer-Ahmad Transfusion Center, Southwestern Iran.

Authors:  Seyed Mehdi Sajjadi; Ali Akbar Pourfathollah; Saeed Mohammadi; Bijan Nouri; Rostam Hassanzadeh; Fariba Rad
Journal:  Iran J Public Health       Date:  2018-07       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.